Showing 61-70 of 1630 results for "".
ASDS: Ethics and Social Media Panel Discussion
https://modernaesthetics.com/conferences/asds-annual-meeting/asds-ethics-and-social-media-panel-discussion/33831/Drs. Fatima Fahs, Kavita Mariwalla, DiAnne Davis, and Evan Rieder recap key points from their panel discussion on ethics and social media at the 2024 American Society for Dermatologic Surgery Annual Meeting.Hindsight in 2020: Finding Value in Virtual Events
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/hindsight-in-2020-finding-value-in-virtual-events/34969/An industry insider shares tips for making the most of virtual events.Genesis: Exosomes and the Future of Skin Regeneration from Dr. David Goldberg’s perspective
https://modernaesthetics.com/topics/regenerative-medicine/genesis-exosomes-and-the-future-of-skin-regeneration-from-dr-david-goldbergs-perspective/36204/Modern Aesthetics sat down with David Goldberg, MD, JD, who led the Genesis: Innovations in Aesthetic Regenerative Medicine meeting block focused on Exosomes.Octane Aesthetics Tech Forum: Longevity Medicine Specialist Dr. Elizabeth Yurth Excited Field Is Entering Aesthetics
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-longevity-medicine-specialist-dr-elizabeth-yurth-excited-field-is-entering-aesthetics/33858/Elizabeth Yurth, MD, ABARM, FAARM, FSSP, is co-founder and chief medical officer of Boulder Longevity Institute in Colorado. Dr. Yurth has a profound background specializing in orthopedic medicine prior to adventuring into the longevity, regenerative, and anti-aging medicine specialty. Dr. Yurth telOctane Aesthetic Tech Forum: Dr. Jason Bloom Dives into Why He’s Held Out on Partnering with Private Equity Firm
https://modernaesthetics.com/conferences/octane-atf/voctane-aesthetic-tech-forum-dr-jason-bloom-dives-into-why-hes-held-out-on-partnering-with-private-equity-firm/33857/Jason Bloom, MD, FACS, is on Octane’s medical aesthetics advisory board. At this year’s forum, Dr. Bloom was part of the Private Equity in Aesthetics Debate. He shared where he stands with Modern Aesthetics.Octane Aesthetics Tech Forum: Octane CEO Bill Carpou Talks Planning Process, Excitement Surrounding Industry
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-octane-ceo-bill-carpou-talks-planning-process-excitement-surrounding-industry-1/33854/Modern Aesthetics sat down with Octane CEO Bill Carpou to discuss the Aesthetics Tech Forum planning process and highlight some panels he was excited to sit in on.Introducing Modern Aesthetic's New Chief Medical Editor as We Relaunch MATV News
https://modernaesthetics.com/series/matv-news/matv-725/33805/In this week's MATV News, we introduce Modern Aesthetic's new chief medical editor Dr. Saami Khalifian; discuss rising concerns over the tween skincare craze; and a major British cosmetic surgery chain ceases operations.MATV News: Endo Pulls Qwo from Market; Merz Aesthetics Adds SaltFacial; Current Trends in Aesthetic Medicine
https://modernaesthetics.com/series/matv-news/matv-news-endo-pulls-qwo-from-market-merz-aesthetics-adds-saltfacial-current-trends-in-aesthetic-medicine/33713/Endo International is ceasing the production and sale of Endo Aesthetics' injectable cellulite treatment Qwo; Merz Aesthetics is adding the SaltFacial to its portfolio through an extended commercial agreement with SaltMED; and New York City dermatologist Dr. Robert Finney discusses trends in aesthetMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News Extra: The Lowdown on Allergan Alle Flash
https://modernaesthetics.com/series/matv-news/matv-news-extra-the-lowdown-on-allergan-alle-flash/33682/Jasson Gilmore, Co-Founder of Allergan Data Labs, discusses the evolution of Allergan's Alle loyalty program and the launch of the Alle Flash. He shares insights on the benefits for patients and providers.